Opening Washington, D.C. office with Judith Buckalew, RN/MPH, as director. Buckalew most recently was a senior manager in Hoffmann-La Roche's Washington office and held previous posts with the Reagan Administration and congressional staffs. ICI also names Donald Ward as VP-external affairs, overseeing an External Affairs Department created by merging the Professional Communications Department and Pharmacy and Government Affairs Department.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth